Polidocanol

聚多卡醇

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NamePolidocanol
Drug Alias Name波利卡醇PEMVarisolve PEM聚乙二醇单十二醚聚桂醇 +[11] 
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsLocalized submental fatSkin MelanomaVaricose Veins +[8] 
Global Approved IndicationsVaricose VeinsEsophageal and Gastric Varices
Approved Indications in ChinaVaricose Veins
Original Approved Country/TerritoryGermany
Original Approved Date1966/05/24
Country/TerritoryUnited StatesPortugalAustralia +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesKaigene IncChemische Fabrik Kreussler & Co Gmbh10xbio Llc
Inactive CompaniesUniversidade do PortoHannover Medical SchoolBoston Scientific Corp +[5] 
Active IndicationsLocalized submental fatVaricose VeinsHemorrhoids +[4] 
Inactive IndicationsSkin MelanomaTennis ElbowTendinopathy +[4] 

Other Information

ATC CodeC05BB02
Related LinksWikipediaDrugBankKEGG